Verdict Medical Devices

FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes

The US FDA has cleared Tandem Diabetes Care’s Control-IQ+ technology for use in individuals aged 18 and above with type 2 diabetes (T2D). The post FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes appeared first on Medical Device Network.

Feb 26, 2025 - 12:29
 0
FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes
The US FDA has cleared Tandem Diabetes Care’s Control-IQ+ technology for use in individuals aged 18 and above with type 2 diabetes (T2D).

The post FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes appeared first on Medical Device Network.

Read More

Tags:

Previous Article

‘Complete nonsense’ – English whisky fights back against SWA criticism

Next Article

Arranging finance is biggest pain point for UK car buyers

Related Posts

AISAP and Amavita partner to bring POCUS to underserved Floridian communities

AISAP and Amavita partner to bring POCUS to underserved...

Feb 9, 2025  0

Navi lands FDA clearance for vascular access placement system

Navi lands FDA clearance for vascular access placement ...

Feb 18, 2025  0

FDA clears Atreon’s bioresorbable synthetic implant for rotator cuff repair

FDA clears Atreon’s bioresorbable synthetic implant for...

Feb 21, 2025  0